Short course of albendazole therapy for neurocysticercosis: A prospective randomized trial comparing three days, eight days and the control group without albendazole

Article

Abstract: Antihelminthic therapy with albendazole for parenchymal cerebral cysticercosis, despite its widespre

Palabras claves:

Autores:

Alarcón F., Cevallos N., Diaz M., Estrada G., Gonzalo Duenãs

Fuentes:

scopus